Naturally Acquired Antibody Responses to the C-Terminal Region of Merozoite Surface Protein 1 ofPlasmodium vivaxin Korea
Open Access
- 1 January 2001
- journal article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 8 (1) , 14-20
- https://doi.org/10.1128/cdli.8.1.14-20.2001
Abstract
We expressed a protein inSaccharomyces cerevisiaein order to evaluate the humoral immune responses to the C-terminal region of the merozoite surface protein 1 ofPlasmodium vivax. This protein (Pv20018) had a molecular mass of 18 kDa and was reactive with the sera of individuals with patent vivax malaria on immunoblotting analysis. The levels of immunoglobulin M (IgM) and IgG antibodies against Pv20018were measured in 421 patients with vivax malaria (patient group), 528 healthy individuals from areas of nonendemicity (control group 1), and 470 healthy individuals from areas of endemicity (control group 2), using the indirect enzyme-linked immunosorbent assay (ELISA) method. To study the longevity of the antibodies, 20 subjects from the patient group were also tested for the antibody levels once a month for 1 year. When the cutoff values for seropositivity were determined as the mean + 3 × standard deviation of the antibody levels in control group 1, both IgG and IgM antibody levels were negative in 98.5% (465 of 472) of control group 2. The IgG and IgM antibodies were positive in 88.1% (371 of 421) and 94.5% (398 of 421) of the patient group, respectively. The IgM antibody became negative 2 to 4 months after the onset of symptoms, whereas the IgG antibody usually remained positive for more than 5 months. In conclusion, indirect ELISA using Pv20018expressed inS. cerevisiaemay be a useful diagnostic method for vivax malaria.Keywords
This publication has 30 references indexed in Scilit:
- Reemergence of Plasmodium vivax Malaria in the Republic of KoreaEmerging Infectious Diseases, 1998
- Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine developmentParasitology Today, 1996
- Expression and immunogenicity of the C-terminus of a major blood-stage surface protein of Plasmodium vivax, Pv20019, secreted from Saccharomyces cerevisiaeImmunology Letters, 1996
- Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP119) variants secreted from Saccharomyces cerevisiaeMolecular and Biochemical Parasitology, 1994
- Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivaxMolecular and Biochemical Parasitology, 1992
- Human IgG responses against the N-terminal region of Merozoite Surface Protein 1 of Plasmodium vivaxMemórias do Instituto Oswaldo Cruz, 1992
- Proteolytic processing of thePlasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domainsMolecular and Biochemical Parasitology, 1991
- Prevalence of antibody to heterologous circumsporozoite protein of Plasmodium vivax in ThailandThe Lancet, 1990
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Repetitive Proteins and Genes of MalariaAnnual Review of Microbiology, 1987